Publication | Closed Access

Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

Hematological MalignancyOncologyAntibody-drug ConjugateHematologyImmunologyAcute Lymphoblastic LeukemiaCamidanlumab TesirineAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyMedicineMyeloid Neoplasia